Workflow
Move Over Eli Lilly: Amgen Could Be The Next Obesity Wonder Stock
AMGNAmgen(AMGN) Seeking Alpha·2024-03-31 15:15
magnetcreative/E+ via Getty Images Eli Lilly (LLY) has been a phenomenal stock to own over the past couple of years. In early 2022, it was trading for about $$230 per share, but today it trades for nearly $$800. This huge run is largely due to the success of its obesity drug, "Zepbound". Eli Lilly shares now trade with a whopping price to earnings ratio of around 60. Analysts expect Eli Lilly to earn about $$12.47 per share, in 2024. For 2025, the earnings estimates are at $$18.16, and for 2026 the estimate ...